ATLANTA, Nov. 9, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that members of management will host one-on-one meetings at the upcoming Canaccord Genuity MedTech, Diagnostics, and Digital Health & Services Forum on Thursday, November 18, 2021. Due to the format of this event no webcast will be available.

Cryolife logo. (PRNewsFoto/CryoLife, Inc.) (PRNewsFoto/CRYOLIFE_ INC_) (PRNewsFoto/CRYOLIFE, INC.)

For more information on the company, please visit CryoLife's website, www.cryolife.com, on the Investor Relations page.

About CryoLife, Inc.
Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. CryoLife markets and sells products in more than 100 countries worldwide. For additional information about CryoLife, visit our website, www.cryolife.com.

Contacts:




CryoLife       

D. Ashley Lee                                                

Executive Vice President, Chief Financial Officer

and Chief Operating Officer

Phone: 770-419-3355

Gilmartin Group LLC

Brian Johnston / Lynn Lewis

Phone: 631-807-1986

investors@cryolife.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cryolife-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-and-digital-health--services-forum-301420321.html

SOURCE CryoLife, Inc.

Copyright 2021 PR Newswire

CryoLife (NYSE:CRY)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas CryoLife.
CryoLife (NYSE:CRY)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas CryoLife.